Caxton Associates (New York)’s Neurocrine Biosciences NBIX Stock Holding History

Caxton Associates (New York)’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$2.49M	Sell
2024 Q1	$2.56M	Buy
2023 Q1	–	Sell
2022 Q4	$582K	Buy
2022 Q3	$318K	Buy
2020 Q3	–	Sell
2020 Q2	$1.16M	Buy
2020 Q1	–	Sell
2019 Q4	$437K	Buy